Literature DB >> 28780180

Neuropathology of Parkinson disease.

Dennis W Dickson1.   

Abstract

INTRODUCTION: Parkinson's disease (PD) is characterized by bradykinesia, rigidity, postural instability and tremor. Several pathologic processes can produce this syndrome, but neurodegeneration accompanied by neuronal inclusions composed of α-synuclein (Lewy bodies) is considered the typical pathologic correlate of PD.
METHODS: The neuropathologic features of PD are reviewed based upon personal experience and review of the literature. Molecular pathology of PD is summarized from cell biological and animal studies.
RESULTS: The pathologic feature that correlates with signs and symptoms of PD is neuronal loss in the substantia nigra with dopaminergic denervation of the striatum. Neuronal degeneration in the substantia nigra preferentially affects the ventrolateral cell group that projects to posterolateral putamen and is accompanied by formation of Lewy bodies composed of aggregated α-synuclein. Some patients with PD are found at autopsy to have other pathologic processes, such as multiple system atrophy, progressive supranuclear palsy and cerebrovascular disease (vascular Parkinsonism). The peripheral autonomic nervous system is also affected. The triggering event in PD is unknown, but recent studies suggest a role for loss of nuclear membrane integrity. Once α-synuclein aggregates forms, evidence supports cell-to-cell propagation.
CONCLUSION: PD is a multisystem synucleinopathy caused by poorly characterized genetic and environmental factors that produces degeneration in selectively vulnerable neuronal populations.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Lewy body; Neuropathology; Parkinson disease; α-Synuclein

Mesh:

Year:  2017        PMID: 28780180      PMCID: PMC5718208          DOI: 10.1016/j.parkreldis.2017.07.033

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  30 in total

Review 1.  Calcium, bioenergetics, and neuronal vulnerability in Parkinson's disease.

Authors:  D James Surmeier; Paul T Schumacker
Journal:  J Biol Chem       Date:  2012-10-19       Impact factor: 5.157

2.  Histones facilitate α-synuclein aggregation during neuronal apoptosis.

Authors:  Peizhou Jiang; Ming Gan; Shu-Hui Yen; Pamela J McLean; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2016-12-21       Impact factor: 17.088

3.  Diversity of pathological features other than Lewy bodies in familial Parkinson's disease due to SNCA mutations.

Authors:  Hiroshige Fujishiro; Akiko Yamashita Imamura; Wen-Lang Lin; Hirotake Uchikado; Margery H Mark; Lawrence I Golbe; Katerina Markopoulou; Zbigniew K Wszolek; Dennis W Dickson
Journal:  Am J Neurodegener Dis       Date:  2013-11-29

4.  Expanding the spectrum of neuronal pathology in multiple system atrophy.

Authors:  Matthew D Cykowski; Elizabeth A Coon; Suzanne Z Powell; Sarah M Jenkins; Eduardo E Benarroch; Phillip A Low; Ann M Schmeichel; Joseph E Parisi
Journal:  Brain       Date:  2015-05-16       Impact factor: 13.501

5.  Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome).

Authors:  M I Papp; J E Kahn; P L Lantos
Journal:  J Neurol Sci       Date:  1989-12       Impact factor: 3.181

6.  Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.

Authors:  Kurt A Jellinger
Journal:  Acta Neuropathol       Date:  2003-07-05       Impact factor: 17.088

7.  Regional distribution of alpha-synuclein pathology in unimpaired aging and Alzheimer disease.

Authors:  Laura Parkkinen; Hilkka Soininen; Irina Alafuzoff
Journal:  J Neuropathol Exp Neurol       Date:  2003-04       Impact factor: 3.685

8.  Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy brain bank.

Authors:  Keith A Josephs; Dennis W Dickson
Journal:  Mov Disord       Date:  2003-09       Impact factor: 10.338

9.  Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro.

Authors:  Jacqueline Burré; Manu Sharma; Theodoros Tsetsenis; Vladimir Buchman; Mark R Etherton; Thomas C Südhof
Journal:  Science       Date:  2010-08-26       Impact factor: 47.728

Review 10.  Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.

Authors:  Ian G McKeith; Bradley F Boeve; Dennis W Dickson; Glenda Halliday; John-Paul Taylor; Daniel Weintraub; Dag Aarsland; James Galvin; Johannes Attems; Clive G Ballard; Ashley Bayston; Thomas G Beach; Frédéric Blanc; Nicolaas Bohnen; Laura Bonanni; Jose Bras; Patrik Brundin; David Burn; Alice Chen-Plotkin; John E Duda; Omar El-Agnaf; Howard Feldman; Tanis J Ferman; Dominic Ffytche; Hiroshige Fujishiro; Douglas Galasko; Jennifer G Goldman; Stephen N Gomperts; Neill R Graff-Radford; Lawrence S Honig; Alex Iranzo; Kejal Kantarci; Daniel Kaufer; Walter Kukull; Virginia M Y Lee; James B Leverenz; Simon Lewis; Carol Lippa; Angela Lunde; Mario Masellis; Eliezer Masliah; Pamela McLean; Brit Mollenhauer; Thomas J Montine; Emilio Moreno; Etsuro Mori; Melissa Murray; John T O'Brien; Sotoshi Orimo; Ronald B Postuma; Shankar Ramaswamy; Owen A Ross; David P Salmon; Andrew Singleton; Angela Taylor; Alan Thomas; Pietro Tiraboschi; Jon B Toledo; John Q Trojanowski; Debby Tsuang; Zuzana Walker; Masahito Yamada; Kenji Kosaka
Journal:  Neurology       Date:  2017-06-07       Impact factor: 9.910

View more
  103 in total

1.  Association of MAPT H1 subhaplotypes with neuropathology of lewy body disease.

Authors:  Michael G Heckman; Koji Kasanuki; Rebecca R Brennan; Catherine Labbé; Emily R Vargas; Alexandra I Soto; Melissa E Murray; Shunsuke Koga; Dennis W Dickson; Owen A Ross
Journal:  Mov Disord       Date:  2019-06-24       Impact factor: 10.338

2.  Altered gastric tone and motility response to brain-stem dopamine in a rat model of parkinsonism.

Authors:  Cecilia Bove; Laura Anselmi; R Alberto Travagli
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-05-01       Impact factor: 4.052

3.  mHealth and wearable technology should replace motor diaries to track motor fluctuations in Parkinson's disease.

Authors:  M Kelley Erb; Daniel R Karlin; Bryan K Ho; Kevin C Thomas; Federico Parisi; Gloria P Vergara-Diaz; Jean-Francois Daneault; Paul W Wacnik; Hao Zhang; Tairmae Kangarloo; Charmaine Demanuele; Chris R Brooks; Craig N Detheridge; Nina Shaafi Kabiri; Jaspreet S Bhangu; Paolo Bonato
Journal:  NPJ Digit Med       Date:  2020-01-17

4.  Diurnal rhythms across the human dorsal and ventral striatum.

Authors:  Kyle D Ketchesin; Wei Zong; Mariah A Hildebrand; Marianne L Seney; Kelly M Cahill; Madeline R Scott; Vaishnavi G Shankar; Jill R Glausier; David A Lewis; George C Tseng; Colleen A McClung
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-12       Impact factor: 11.205

5.  Intragastric Administration of Casein Leads to Nigrostriatal Disease Progressed Accompanied with Persistent Nigrostriatal-Intestinal Inflammation Activited and Intestinal Microbiota-Metabolic Disorders Induced in MPTP Mouse Model of Parkinson's Disease.

Authors:  Xinrong Liu; Shuya Liu; Yong Tang; Zhengjia Pu; Hong Xiao; Jieying Gao; Qi Yin; Yan Jia; Qunhua Bai
Journal:  Neurochem Res       Date:  2021-03-15       Impact factor: 3.996

6.  A novel multi-marker discovery approach identifies new serum biomarkers for Parkinson's disease in older people: an EXosomes in PArkiNson Disease (EXPAND) ancillary study.

Authors:  Riccardo Calvani; Anna Picca; Giovanni Landi; Federico Marini; Alessandra Biancolillo; Hélio José Coelho-Junior; Jacopo Gervasoni; Silvia Persichilli; Aniello Primiano; Annalaura Arcidiacono; Andrea Urbani; Maurizio Bossola; Anna Rita Bentivoglio; Matteo Cesari; Roberto Bernabei; Maria Rita Lo Monaco; Emanuele Marzetti
Journal:  Geroscience       Date:  2020-05-26       Impact factor: 7.713

Review 7.  The Basal Ganglia: More than just a switching device.

Authors:  Tiziana Marilena Florio; Eugenio Scarnati; Ilaria Rosa; Davide Di Censo; Brigida Ranieri; Annamaria Cimini; Angelo Galante; Marcello Alecci
Journal:  CNS Neurosci Ther       Date:  2018-06-07       Impact factor: 5.243

8.  Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson's disease.

Authors:  Qian Ren; Min Ma; Jun Yang; Risa Nonaka; Akihiro Yamaguchi; Kei-Ichi Ishikawa; Kenta Kobayashi; Shigeo Murayama; Sung Hee Hwang; Shinji Saiki; Wado Akamatsu; Nobutaka Hattori; Bruce D Hammock; Kenji Hashimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-07       Impact factor: 11.205

9.  TREM2 deficiency aggravates α-synuclein-induced neurodegeneration and neuroinflammation in Parkinson's disease models.

Authors:  Ying Guo; Xinbing Wei; Hua Yan; Yue Qin; Shaoqi Yan; Jia Liu; Yong Zhao; Fan Jiang; Haiyan Lou
Journal:  FASEB J       Date:  2019-08-01       Impact factor: 5.191

10.  Pharmacogenetic profile and the development of the dyskinesia induced by levodopa-therapy in Parkinson's disease patients: a population-based cohort study.

Authors:  Erinaldo Ubirajara Damasceno Dos Santos; Isaura Isabelle Fonseca Gomes da Silva; Amdore Guescel C Asano; Nadja Maria Jorge Asano; Maria De Mascena Diniz Maia; Paulo Roberto Eleutério de Souza
Journal:  Mol Biol Rep       Date:  2020-11-05       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.